Therapeutic Solutions International

Biotechnology company engaged in the development of products for females.

Launch date

2007

Employees

Market cap

Enterprise valuation

€4m (Public information from Sep 2024)

Oceanside California (HQ)

http://therapeuticsolutionsint.com

https://www.facebook.com/pages/Therapeutic-Solutions-International-Inc/841831502510044?fref=ts&rf=855958927821572 https://www.linkedin.com/company/therapeutic-solutions-international-inc

Revenues, earnings & profits over time

USD	2017	2018	2019	2020	2021	2022	2023
Revenues	-	-	<1m	<1m	<1m	<1m	<1m
% growth	-	-	-	128 %	133 %	42 %	(52 %)
EBITDA	-	-	(1.0m)	(1.8m)	(2.3m)	(2.9m)	(1.7m)
% EBITDA margin	-	-	(3770 %)	(2950 %)	(1566 %)	(1425 %)	(1692 %)
Profit	-	-	(1.7m)	(2.2m)	(3.0m)	(3.7m)	(2.2m)
% profit margin	-	-	(6173 %)	(3510 %)	(2029 %)	(1779 %)	(2192 %)
EV / revenue	-	-	207.5x	241.2x	466.1x	81.1x	47.1x
EV / EBITDA	-	-	-5.5x	-8.2x	-29.8x	-5.7x	-2.8x
R&D budget	-	-	<1m	<1m	<1m	1.4m	<1m
R&D % of revenue	-	-	101 %	897 %	545 %	697 %	566 %

Date	Investors	Amount	Round
Apr 2009	N/A	N/A	IPO
May 2015	N/A	$100k	Post IPO Equity
Jan 2020*	TRITON FUNDS	$500k	Post IPO Equity
Sep 2022*	GHS Investments	$10.0m	Post IPO Equity
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.